Absci ABSI
NASDAQ ABSI
$8.82 +0.02 (+0.23%)
As of: Sep 4, 2026 · 3:59 PM EDT

Absci (ABSI) Free Cash Flow (2020 - 2026)

Absci (ABSI) posted Free Cash Flow of -$26.3 million for Q1 2026, up 9.43% sequentially from -$29.1 million in Q4 2025, and down 20.46% YoY from -$33.1 million in Q1 2025.

Analysis

Absci (ABSI) Free Cash Flow (2020 - 2026) Analysis & Trends

Absci has reported Free Cash Flow for 7 years, with the latest figure at -$26.3 million in Q1 2026.

  • Quarterly Free Cash Flow fell 20.46% year-over-year to -$26.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$98.5 million (down 28.25% YoY) and the FY2025 annual result came in at -$94.0 million, down 29.15% from the prior year.
  • Free Cash Flow advanced to -$26.3 million in Q1 2026 per ABSI's latest filing, from -$29.1 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$2.9 million in Q4 2022 and troughed at -$32.7 million in Q3 2022.
  • A 5-year average of -$19.9 million and a median of -$20.2 million in 2023 frame the typical range for Free Cash Flow.
  • The widest YoY moves for Free Cash Flow: up 78.02% in 2022, down 2586.51% in 2022.
  • Over 5 years, Free Cash Flow stood at -$2.9 million in 2022, then plunged by 407.55% to -$14.9 million in 2023, then dropped by 15.91% to -$17.3 million in 2024, then sank by 68.13% to -$29.1 million in 2025, then grew by 9.43% to -$26.3 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$26.3 million, -$29.1 million, and -$26.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 Absci 1.39 Bn 1.19 Bn - -27.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -27.57 Mn
Mar 31, 2026 -26.34 Mn
Dec 31, 2025 -29.08 Mn
Sep 30, 2025 -25.99 Mn
Jun 30, 2025 -17.10 Mn
Mar 31, 2025 -21.86 Mn
Dec 31, 2024 -17.12 Mn
Sep 30, 2024 -20.78 Mn
Jun 30, 2024 -17.18 Mn
Mar 31, 2024 -17.86 Mn
Dec 31, 2023 -14.94 Mn
Sep 30, 2023 -10.67 Mn
Jun 30, 2023 -19.49 Mn
Mar 31, 2023 -20.40 Mn
Dec 31, 2022 -19.13 Mn
Sep 30, 2022 -23.91 Mn
Jun 30, 2022 -26.47 Mn
Mar 31, 2022 -28.01 Mn
Dec 31, 2021 -25.40 Mn
Sep 30, 2021 -27.37 Mn